Genus Company Profile

✉ Email this page to a colleague

GENUS has twenty-nine approved drugs.

There are seven US patents protecting GENUS drugs.

There are forty-five patent family members on GENUS drugs in twenty-one countries and eighteen supplementary protection certificates in six countries.

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Genus Lifesciences	LEVOLET	levothyroxine sodium	TABLET;ORAL	021137-008	Jun 6, 2003	AB1,AB2,AB3,AB4	RX	No	No	10,231,931	⤷ Sign Up	Y			⤷ Sign Up
Genus	AMCINONIDE	amcinonide	LOTION;TOPICAL	076329-001	Nov 6, 2002		RX	No	Yes		⤷ Sign Up				⤷ Sign Up
Genus Lifesciences	LEVOLET	levothyroxine sodium	TABLET;ORAL	021137-005	Jun 6, 2003	AB1,AB2,AB3,AB4	RX	No	No	10,231,931	⤷ Sign Up	Y			⤷ Sign Up
Genus	AMCINONIDE	amcinonide	OINTMENT;TOPICAL	076096-001	Nov 19, 2002	AB	RX	No	Yes		⤷ Sign Up				⤷ Sign Up
Genus	MEPERIDINE HYDROCHLORIDE	meperidine hydrochloride	TABLET;ORAL	040893-002	Jun 24, 2009		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Genus	NYSTATIN	nystatin	SUSPENSION;ORAL	065148-001	Jun 28, 2005	AA	RX	No	No		⤷ Sign Up				⤷ Sign Up
Genus	PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE	phenylephrine hydrochloride; promethazine hydrochloride	SYRUP;ORAL	040654-001	Dec 7, 2006	AA	RX	No	Yes		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Genus Lifesciences	YOSPRALA	aspirin; omeprazole	TABLET, DELAYED RELEASE;ORAL	205103-001	Sep 14, 2016	6,926,907	⤷ Sign Up
Genus Lifesciences	YOSPRALA	aspirin; omeprazole	TABLET, DELAYED RELEASE;ORAL	205103-001	Sep 14, 2016	9,364,439	⤷ Sign Up
Genus Lifesciences	YOSPRALA	aspirin; omeprazole	TABLET, DELAYED RELEASE;ORAL	205103-002	Sep 14, 2016	9,364,439	⤷ Sign Up
Genus Lifesciences	YOSPRALA	aspirin; omeprazole	TABLET, DELAYED RELEASE;ORAL	205103-002	Sep 14, 2016	8,206,741	⤷ Sign Up
Genus Lifesciences	YOSPRALA	aspirin; omeprazole	TABLET, DELAYED RELEASE;ORAL	205103-002	Sep 14, 2016	6,926,907	⤷ Sign Up
Genus Lifesciences	YOSPRALA	aspirin; omeprazole	TABLET, DELAYED RELEASE;ORAL	205103-001	Sep 14, 2016	8,206,741	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Delayed-release Tablets	81 mg/40 mg	➤ Subscribe	2016-10-14

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration
Morocco	33296	⤷ Sign Up
Eurasian Patent Organization	201491285	⤷ Sign Up
Denmark	2421513	⤷ Sign Up
Israel	247034	⤷ Sign Up
Japan	2012524724	⤷ Sign Up
New Zealand	710384	⤷ Sign Up
Eurasian Patent Organization	028049	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration

Subscribe to access the full database, or Sign Up
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0480717	98C0025	Belgium	⤷ Sign Up	PRODUCT NAME: LOSARTAN POTASSIUM; HYDROCHLOROTHIAZIDE; NAT. REGISTRATION NO/DATE: NL 20 037 19950215; FIRST REGISTRATION: FR - NL 20 037 19950215
1718641	SPC/GB12/028	United Kingdom	⤷ Sign Up	PRODUCT NAME: AZILSARTAN MEDOXOMIL AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, INCLUDING THE POTASSIUM SALT; REGISTERED: UK EU/1/11/734/001-011 20111209
1441735	2008/010	Ireland	⤷ Sign Up	PRODUCT NAME: RALTEGRAVIR OR A PHARMECEUTICALLY ACCEPTABLE SALT THEREOF, ESPECIALLY THE POTASSIUM SALT; NAT AUTHORISTION NO/DATE: EU/1/07/436/001-002 20071220;
1534313	92923	Luxembourg	⤷ Sign Up	PRODUCT NAME: UNE SOLUTION D'IRRIGATION OCULAIRE COMPRENANT DE LA PHENYLEPHRINE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELLE-CI ET DU KETOROLAC OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; FIRST REGISTRATION: 20150730
0809498	SPC/GB10/012	United Kingdom	⤷ Sign Up	PRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112
1441735	08C0026	France	⤷ Sign Up	PRODUCT NAME: RALTEGRAVIR POTASSIUM; REGISTRATION NO/DATE: EU/1/07/436/001 20080102
0809498	10C0038	France	⤷ Sign Up	PRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.